Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adjuvant Therapy for Bladder Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 5 of 0 results

Large-scale testing (Phase 3)Study completedNCT00003701
What this trial is testing

Combination Chemotherapy in Treating Patients With Bladder Cancer

Who this might be right for
Bladder CancerUrethral Cancer
Eastern Cooperative Oncology Group 490
Not applicableLooking for participantsNCT07424560
What this trial is testing

Multiplex Mutation Detection Using Mass Spectrometry in Bladder Cancer

Who this might be right for
Bladder CancerBladder Cancer RecurrenceAdjuvant Therapy for Bladder Cancer+1 more
Zhilong Dong 400
Large-scale testing (Phase 3)WithdrawnNCT07313891
What this trial is testing

Adjuvant NDV-01 (Sustained-release Gemcitabine-docetaxel) for the Treatment of Intermediate Risk NMIBC Following TURBT

Who this might be right for
Bladder (Urothelial, Transitional Cell) Cancer Superficial (Non-Invasive)Bladder (Urothelial, Transitional Cell) CancerUrothelial Carcinoma Bladder+1 more
Relmada Therapeutics, Inc.
Testing effectiveness (Phase 2)Ended earlyNCT01042795
What this trial is testing

Trial of Adjuvant Sutent for Patients With High Risk Urothelial Carcinoma After Neoadjuvant Chemotherapy and Cystectomy

Who this might be right for
Urothelial CarcinomaBladder Cancer
University of Michigan 7
Early research (Phase 1)Looking for participantsNCT06586255
What this trial is testing

Adjuvant Concurrent Immunotherapy and Radiotherapy for the Treatment of Bladder Cancer

Who this might be right for
Urothelial Carcinoma BladderBladder Cancer
Abramson Cancer Center at Penn Medicine 10